8-K - Intellia Therapeutics, Inc. (0001652130) (Filer)
Published . Updated .
Key takeaways
- 8-K - Intellia Therapeutics filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
- Exposed: NTLA
- Market reaction: NTLA −9.3% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Intellia Therapeutics filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- NTLA Intellia Therapeutics-14.7% 9d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Intellia Therapeutics belongs to, so it often moves with news about it.
- IDXX IDEXX Laboratories+34.6% 16d
IDEXX Laboratories is a peer of Intellia Therapeutics in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- LNTH Lantheus Holdings+1.3% 30d
Lantheus Holdings is a peer of Intellia Therapeutics in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- NEOG Neogen-6.5% 30d
Neogen is a peer of Intellia Therapeutics in in vitro and in vivo diagnostic substances; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| NTLA | +7.51% | -5.28% | base | -10.07% | -7.88% | -1.71% | -9.34% |
| XLV | -2.96% | -2.66% | base | -2.36% | -2.53% | -0.67% | -0.41% |
| IDXX | -17.67% | -3.96% | base | -4.09% | -3.36% | +1.06% | -0.45% |
| LNTH | -0.79% | -0.80% | base | -0.43% | -0.52% | -0.14% | +0.49% |
| NEOG | -1.61% | -4.98% | base | -6.18% | -5.50% | -3.01% | -6.27% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001193125-26-448673 Size: 399 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Intellia Therapeutics (NTLA) since “8-K - Intellia Therapeutics, Inc. (0001652130) (Filer),” compared with the market
Since the first closing price after “8-K - Intellia Therapeutics, Inc. (0001652130) (Filer),” Intellia Therapeutics (NTLA) is -6.92%.
| Company | When | Move | Status |
|---|---|---|---|
| IDXX | that day | -4.09% | final price |
| IDXX | the next day | -3.36% | final price |
| IDXX | two days later | +1.06% | final price |
| IDXX | three days later | -0.45% | final price |
| IDXX | three days earlier | -3.96% | final price |
| IDXX | five days earlier | -17.67% | final price |
| LNTH | that day | -0.43% | final price |
| LNTH | the next day | -0.52% | final price |
| LNTH | two days later | -0.14% | final price |
| LNTH | three days later | +0.49% | final price |
| LNTH | three days earlier | -0.80% | final price |
| LNTH | five days earlier | -0.79% | final price |
| NEOG | that day | -6.18% | final price |
| NEOG | the next day | -5.50% | final price |
| NEOG | two days later | -3.01% | final price |
| NEOG | three days later | -6.27% | final price |
| NEOG | three days earlier | -4.98% | final price |
| NEOG | five days earlier | -1.61% | final price |
| Intellia Therapeutics (NTLA) | that day | -10.07% | final price |
| Intellia Therapeutics (NTLA) | the next day | -7.88% | final price |
| Intellia Therapeutics (NTLA) | two days later | -1.71% | final price |
| Intellia Therapeutics (NTLA) | three days later | -9.34% | final price |
| Intellia Therapeutics (NTLA) | three days earlier | -5.28% | final price |
| Intellia Therapeutics (NTLA) | five days earlier | +7.51% | final price |
| XLV | that day | -2.36% | final price |
| XLV | the next day | -2.53% | final price |
| XLV | two days later | -0.67% | final price |
| XLV | three days later | -0.41% | final price |
| XLV | three days earlier | -2.66% | final price |
| XLV | five days earlier | -2.96% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Gilbert Cisneros sold Lantheus Holdings (LNTH), worth $1,001 - $15,000 on 15 Oct 2026. That is 21 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros sold Lantheus Holdings (LNTH), worth $1,001 - $15,000 on 14 Oct 2026. That is 22 days before publication. Filed 10 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Intellia Therapeutics (NTLA)
Companies carried with this story
- NTLA Intellia Therapeutics
Intellia Therapeutics (NTLA) is linked, with no stored direction, high confidence in the 5 Nov 2026 story “8-K - Intellia Therapeutics, Inc. (0001652130) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> NTLA
How “8-K - Intellia Therapeutics, Inc. (0001652130) (Filer)” reaches Intellia Therapeutics (NTLA)
On 5 Nov 2026, “8-K - Intellia Therapeutics, Inc. (0001652130) (Filer)” is the story that connects Intellia Therapeutics (NTLA) to this story.
For Intellia Therapeutics (NTLA), the reason on file says SEC 8-K filing -> direct issuer disclosure -> NTLA
Dates and price levels for Intellia Therapeutics (NTLA)
NTLA traded between 10.46 and 13.21 across 9 sessions. The latest close on file is 10.55.
What the saved facts support for Intellia Therapeutics (NTLA)
14 out of 100
“8-K - Intellia Therapeutics, Inc. (0001652130) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.